Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-12-17 4:40 pm Purchase |
2020-12-07 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
RA CAPITAL MANAGEMENT L.P. | 451,932 11.600% |
451,932 (New Position) |
Filing History |
| 2020-12-16 5:24 pm Purchase |
2009-02-28 | 13D | Solid Biosciences Inc. SLDB |
RA CAPITAL MANAGEMENT L.P. | 665,105 11.800% |
360,360 (+118.25%) |
Filing History |
| 2020-12-02 4:31 pm Purchase |
2020-11-22 | 13G | Iterum Therapeutics plc ITRM |
RA CAPITAL MANAGEMENT L.P. | 666,667 18.900% |
666,667 (New Position) |
Filing History |
| 2020-10-09 4:29 pm Purchase |
2020-09-30 | 13G | Cardiff Oncology, Inc. CRDF |
RA CAPITAL MANAGEMENT L.P. | 3,290,000 10.900% |
3,290,000 (New Position) |
Filing History |
| 2020-10-07 5:00 pm Purchase |
2020-10-05 | 13D | Eidos Therapeutics Inc. EIDX |
RA CAPITAL MANAGEMENT L.P. | 1,798,339 4.700% |
1,798,339 (New Position) |
Filing History |
| 2020-09-21 5:24 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA CAPITAL MANAGEMENT L.P. | 4,736,214 23.800% |
1,300,000 (+37.83%) |
Filing History |
| 2020-09-10 4:29 pm Purchase |
2020-03-31 | 13G | Ascendis Pharma A/S ASND |
RA CAPITAL MANAGEMENT L.P. | 5,818,862 10.900% |
1,633,520 (+39.03%) |
Filing History |
| 2020-08-05 4:30 pm Purchase |
2009-02-28 | 13D | iTeos Therapeutics, Inc. ITOS |
RA CAPITAL MANAGEMENT L.P. | 4,417,259 13.200% |
4,417,259 (New Position) |
Filing History |
| 2020-07-24 4:34 pm Purchase |
2009-02-28 | 13D | Nkarta, Inc. NKTX |
RA CAPITAL MANAGEMENT L.P. | 5,605,129 17.200% |
5,605,129 (New Position) |
Filing History |
| 2020-07-10 4:33 pm Purchase |
2020-06-30 | 13G | Vaxcyte, Inc. PCVX |
RA CAPITAL MANAGEMENT L.P. | 5,489,181 10.800% |
5,489,181 (New Position) |
Filing History |
| 2020-07-10 4:30 pm Purchase |
2009-02-28 | 13D | 89bio, Inc. ETNB |
RA CAPITAL MANAGEMENT L.P. | 3,436,214 20.400% |
275,000 (+8.70%) |
Filing History |
| 2020-07-10 4:24 pm Sale |
2020-03-03 | 13G | Verastem, Inc. VSTM |
RA CAPITAL MANAGEMENT L.P. | 760,771 5.600% |
-789,617 (-50.93%) |
Filing History |
| 2020-06-25 5:02 pm Purchase |
2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA CAPITAL MANAGEMENT L.P. | 9,011,651 23.400% |
9,011,651 (New Position) |
Filing History |